Compare ESQ & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESQ | IRMD |
|---|---|---|
| Founded | 2006 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.2M | 1.2B |
| IPO Year | 2017 | 2014 |
| Metric | ESQ | IRMD |
|---|---|---|
| Price | $108.60 | $98.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $113.00 | $72.00 |
| AVG Volume (30 Days) | 59.8K | ★ 86.5K |
| Earning Date | 01-22-2026 | 02-12-2026 |
| Dividend Yield | 0.66% | ★ 0.69% |
| EPS Growth | ★ 14.70 | 13.00 |
| EPS | ★ 5.68 | 1.65 |
| Revenue | ★ $131,743,000.00 | $80,511,268.00 |
| Revenue This Year | N/A | $15.17 |
| Revenue Next Year | $18.55 | $10.15 |
| P/E Ratio | ★ $18.77 | $59.49 |
| Revenue Growth | ★ 13.37 | 12.91 |
| 52 Week Low | $68.90 | $47.48 |
| 52 Week High | $110.71 | $100.01 |
| Indicator | ESQ | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.50 | 62.30 |
| Support Level | $100.75 | $94.54 |
| Resistance Level | $107.88 | $100.01 |
| Average True Range (ATR) | 2.77 | 2.51 |
| MACD | -0.11 | -0.39 |
| Stochastic Oscillator | 76.32 | 76.79 |
Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.